It's National #Cholesterol Education Month! Too often, meds solve one problem but worsen another. Join our FREE webinar tmrw @ 1PM ET and discover how to prescribe with the whole patient in mind using real-world case studies. FREE to attend! Reserve your spot now. 🔗 ow.ly/UglC50WOnWk #Cardiosky

📉Lower LDL-C for longer is better. The NLA’s new guidance simplifies LDL-C management for adults — helping clinicians & patients improve evidence-based measurement and treatment of LDL-C. Read the guidelines & recommendations: www.lipidjournal.com/article/S193....

🎙️New Industry Innovations Podcast! Dr. Peter Jones chats with Dr. Bruce Given about the RNA interference revolution in lipidology. Supported by Arrowhead Pharmaceuticals, Inc. Listen now: lipid.org/industryinno... #LipidScience #RNAi

📅1 week away! Join the next #NLAPracticalPearls webinar on June 12 at 12:30pm ET with Dr. Nicholas Marston: TG-Targets: ApoC3 & ANGPTL3. Free, CME/CE credit, and full of practical lipid insights. Don’t miss it! 🔗Register: lipid.org/practicalpea... #Cardiosky

📣In case you missed it at #NLASessions: The NLA released its Expert Clinical Review on Multidisciplinary Teams in Clinical Lipidology and Cardiometabolic Care.🩺🫀 Read the article & download the clinician infographic: ow.ly/poRE50W4smS

We're eager to touch down in Miami for #NLASessions, where insights from two of our completed Phase 3 studies—BROOKLYN and BROADWAY—will be shared along with 9 additional analyses. We hope to see you in The Magic City next week! @nationallipid.bsky.social

The NLA and @foundationofnla.bsky.social urge CMS and Administrator Oz to include LDL-C measurement in CMS quality measurement programs. Effective LDL-C management is key to reducing ASCVD, the leading cause of death in the U.S. Read the full statement: t.co/pX941QO6jm #Cardiosky

🚨Lipid Panel happening NEXT week, May 20 @ 8pm ET! Join top clinical pharmacists as they break down what every clinician should know about pharmacology in lipid management. 🌟Don’t miss it! Register at lipid.org/thelipidpanel #LipidPanel #Pharmacology #LipidManagement #CME

Join us May 8 at 12PM ET for "Lipoprotein(a) in Focus" with Dr. Michael Wilkinson! Review Lp(a) structure, patient care strategies, and future therapies. Don’t miss these practical pearls! 🔗Register now! lipid.org/practicalpea... #lipids #cardiology #cardiosky #lpa

Happening TODAY @ 8 PM ET‼️ Sign up at lipid.org/thelipidpanel

📣 What’s now and what’s next for Lp(a)? Join us Tues, 4/29 for Lp(a) Today and Tomorrow featuring Dr. Tsimikas & Dr. Mintz to explore emerging insights + therapies in Lp(a) management. 📅April 29 |🕒8pm ET 🔗Register now: lipid.org/thelipidpanel #LipidPanel #Lpa #Cardiosky

Register for #NLASessions to join! 🔗 lipid.org/sessions

📣NEW expert clinical review from the NLA on #FCS. 📄Read the full-length article: ow.ly/ALrc50VBAv6

Don't miss our latest JCL Roundtable!🗣️ Drs. Carol F. Kirkpatrick, Kristina S. Petersen, Michael J. Wilkinson, & Kevin C. Maki discuss dietary recommendations for #ASCVD prevention. Read the conversation👉 lipidjournal.com/article/S1933-2874(25)00052-2/fulltext #cardiosky

📢NEW NLA & AGS expert clinical consensus on managing #hypercholesterolemia in adults older than 75 years without a history of #ASCVD. Read the article now: sciencedirect.com/science/arti... #Cardiosky

Read the joint Consensus from @aspcardio.bsky.social & @nationallipid.bsky.social! Recognition & Management of Persistent Chylomicronemia: A comprehensive expert clinical consensus by the NLA & ASPC. ow.ly/NU9g50VqxCE @michaeldshapiro.bsky.social @erinmichos.bsky.social #NationalTriglyceridesDay

We are excited to share our Joint Expert Clinical Consensus with @aspcardio.bsky.social! To celebrate #NationalTriglycerideDay, check out our article on Persistent Chylomicronemia. @lipidjournal.bsky.social #CardioSky 🔗 lipidjournal.com/article/S193...

It's #NationalTriglycerideDay! Patient & clinician education is key to raising awareness. In support of @foundationofnla.bsky.social, we’re sharing top resources to expand your TG knowledge! #CardioSky

🎙️NEW episode of Lipid Insights! We sat down with dietitians Anna Biggins MPH, RDN, LD, & Lauren Williams, MCN, RDN, LD to discuss recent fad diets & supplements. 🎧Listen now: lipid.org/lipidinsights 🔗Apple: podcasts.apple.com/us/podcast/s... 🔗Spotify: open.spotify.com/episode/3NC2...

Today is #DiabetesAlertDay — a day to remind people to take charge of their health! Lipid specialists play a vital role in helping certain patients manage diabetes.🤝 📚Take a look at some of our recent @lipidjournal.bsky.social articles on diabetes:

NLA Past-President Dr. James A. Underberg discussing new & exciting FNLA content! Check out great triglyceride resources for patients AND clinicians at learnyourlipids.com/basics/trigl....

If you want to hear some great and succinct lipid talk - Give a listen to the Lipid Legends Podcasts Visit www.healio.com/cme/mededtalks/lipidlegends @aspcardio.bsky.social @nationallipid.bsky.social @escardio.bsky.social @familyheartfdn.bsky.social

Collaboration between nephrologists & lipid specialists is vital to managing CKD & reducing ASCVD risk. For #WorldKidneyDay, check out these great resources!

🎙️NEW episode of Lipid Insights! Dietitian and diabetes specialist Shannon Christen RD, CDCES, CCHP, discusses new #FCS research, therapies, and recent developments.💊 🎧Listen now: ow.ly/grnQ50VfSm7 🔗Apple: ow.ly/PGFL50VfSm6 🔗Spotify: ow.ly/hLM150VfSm9

📢 Don’t miss The Lipid Panel on March 25 at 8 PM ET! 🫀 Join panelists Drs. Peter Libby & Ron Blankstein for a deep dive into CAD, plaque assessment & why it matters for ASCVD prevention. FREE CME! 🔗 Register now: lipid.org/thelipidpanel #LipidPanel #Cardiology #ASCVD #CME

The FNLA launched a new triglyceride "basics" web page. Check it out and mark your calendars for National Triglycerides Day on March 28 🔗http://learnyourlipids.com/basics/triglycerides/ Follow @foundationofnla.bsky.social for more triglyceride content this month!

We’re back for Season 6 of Lipid Insights!🎙️🙌 Our first episode in 2025 explores how nutrition-related clinical trials shape dietary recommendations for health & disease treatment.🥗🩺 🎧Listen now: lipid.org/lipidinsights 🔗Apple: ow.ly/jUiz50VajZk 🔗Spotify: ow.ly/Qwjc50VajZh

📣Exciting news in lipidology! The FDA has approved Mirum Pharmaceuticals' CTEXLI™ (chenodiol) tablets for treating CTX, the first and only treatment approved for this rare genetic disorder. Read the press release: ir.mirumpharma.com/news-events/...

Heart disease is the #1 cause of death in women, with rising cases in younger women. Many don’t get the lipid care they need. Managing LDL-C & TG is key — especially in pregnancy — to reduce risks. Learn more this #HeartMonth: ow.ly/LLJq50V4kz1

Black individuals are more likely to have elevated Lp(a), a major #ASCVD risk factor — yet testing disparities exist. The NLA is committed to raising awareness, advancing research, & advocating for equitable screening not just during #BlackHistoryMonth, but every day.

New research confirms Lp(a) plays a key role in CVD risk. The NLA now recommends every adult have their Lp(a) levels measured at least once. Read the update & download resources: lipid.org/nla/focused-update-2019-nla-scientific-statement-use-lipoproteina-clinical-practice. #HeartMonth #HeartHealth

Happening TODAY at 2 p.m. EST!📢 Join us for the first webinar in our rebranded NLA chapter series!🌟 Sponsored by SWLA, this Practical Pearls webinar covers Plozasiran, a new triglyceride-lowering drug. 🔗Register now: ow.ly/3iQe50UPSgm

Our second #AmericanHeartMonth post highlights a collaborative journal publication with @aspcardio.bsky.social!🫀 Our joint statement explains why LDL-C measurement is crucial for improving population-wide lipid control. 📃Article: ow.ly/XVvQ50UVJbl 🎙️Podcast: ow.ly/Eben50UVJbo

Join us NEXT Thursday, Feb. 13 for the first installment of our rebranded NLA chapter webinar series. Sponsored by SWLA, this session will cover Plozasiran, a new triglyceride-lowering drug. Learn how it could benefit lipid management — sign up today!🔗 ow.ly/3iQe50UPSgm

🫀To kick off our #AmericanHeartMonth series, we begin with sharing our recent position statement on the importance of a lipid specialty taxonomy code. Check out some key quotes from "Lipidology: The Time is Now for Specialty Recognition", published in JCL. ➡️

Big news in lipidology!🎉 The FDA has approved TRYNGOLZA™ (olezarsen) 80mg injection — the 1st treatment for adults with familial chylomicronemia syndrome (FCS) to lower triglycerides, alongside diet. Read the press release: ir.ionis.com/news-release... #LipidScience

🚨 Big news in lipidology! 🚨 @newamsterdampharma.bsky.social's Phase 3 BROADWAY trial results for Obicetrapib are in: ✅ 33% LDL-C reduction at day 84 (vs placebo) ✅ 21% reduction in MACE after 1 year A promising advance for patients with #ASCVD & HeFH! #Cardiology #Lipidology

President Christie Ballantyne, M.D. sat down with Dr. Gabrielle Lyon and discussed all things cardiovascular health, metabolic wellness, and disease prevention.🩺 🔗Give it a listen: dr-gabrielle-lyon.captivate.fm/episode/hear...

A must read! @lipidjournal.bsky.social #NLA

Welcome to the National Lipid Association's official Bluesky page! Follow our other socials: @lipidjournal.bsky.social & @foundationofnla.bsky.social